Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kovacic, 2001, Mechanisms of carcinogenesis: focus on oxidative stress and electron transfer, Curr. Med. Chem., 8, 773, 10.2174/0929867013373084
Ridnour, 2005, Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1, Proc. Natl. Acad. Sci. U. S. A., 102, 13147, 10.1073/pnas.0502979102
Valko, 2001, Oxygen free radical generating mechanisms in the colon: do the semiquinones of Vitamin K play a role in the aetiology of colon cancer, Biochim. Biophys. Acta, 1527, 161, 10.1016/S0304-4165(01)00163-5
Droge, 2002, Free radicals in the physiological control of cell function, Physiol. Rev., 82, 47, 10.1152/physrev.00018.2001
Hensley, 1998, Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation, J. Neurosci., 18, 8126, 10.1523/JNEUROSCI.18-20-08126.1998
Butterfield, 2002, Evidence that amyloid â-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death, Neurobiol. Aging, 23, 655, 10.1016/S0197-4580(01)00340-2
Dexter, 1989, Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease, J. Neurochem., 52, 381, 10.1111/j.1471-4159.1989.tb09133.x
Pedersen, 1998, Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients, Ann. Neurol., 44, 819, 10.1002/ana.410440518
Beal, 1997, Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis, Ann. Neurol., 42, 644, 10.1002/ana.410420416
Smith, 1997, Widespread peroxynitrite-mediated damage in Alzheimer’s disease, J. Neurosci., 17, 2653, 10.1523/JNEUROSCI.17-08-02653.1997
Good, 1998, Protein nitration in Parkinson’s disease, J. Neuropathol. Exp. Neurol., 57, 338, 10.1097/00005072-199804000-00006
Aoyama, 2000, Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases, Ann. Neurol., 47, 524, 10.1002/1531-8249(200004)47:4<524::AID-ANA19>3.0.CO;2-5
Giasson, 2000, Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions, Science, 290, 985, 10.1126/science.290.5493.985
Giasson, 2000, A panel of epitope-specific antibodies detects protein domains distributed throughout human α-synuclein in lewy bodies of Parkinson’s disease, J. Neurosci. Res., 59, 528, 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0
Horiguchi, 2003, Nitration of tau protein is linked to neurodegeneration in tauopathies, Am. J. Pathol., 163, 1021, 10.1016/S0002-9440(10)63462-1
Valko, 2006, Free radicals, metals and antioxidants in oxidative stress-induced cancer, Chem. Biol. Interact., 160, 1, 10.1016/j.cbi.2005.12.009
Valko, 2005, Metals, toxicity and oxidative stress, Curr. Med. Chem., 12, 1161, 10.2174/0929867053764635
Parthasarathy, 1999, Oxidants and antioxidants in atherogenesis: an appraisal, J. Lipid Res., 40, 2143, 10.1016/S0022-2275(20)32089-7
Frei, 1997
Chatterjee, 2007, Biochemical and molecular evaluation of neutrophil NOS in spontaneously hypertensive rats, Cell. Mol. Biol., 53, 84
Halliwell, 1999
Miller, 1990, Transition metals as catalysts of autoxidation reactions, Free Radic. Biol. Med., 8, 95, 10.1016/0891-5849(90)90148-C
Kovacic, 2005, Mechanism of mitochondrial uncouplers, inhibitors, and toxins: focus on electron transfer, free radicals, and structure-activity relationships, Curr. Med. Chem., 12, 2601, 10.2174/092986705774370646
Valko, 2004, Role of oxygen radicals in DNA damage and cancer incidence, Mol. Cell. Biochem., 266, 37, 10.1023/B:MCBI.0000049134.69131.89
Ghafourifar, 2005, Mitochondrial nitric oxide synthase, Trends Pharmacol. Sci., 26, 190, 10.1016/j.tips.2005.02.005
Bergendi, 1999, Chemistry, physiology and pathology of free radicals, Life Sci., 65, 1865, 10.1016/S0024-3205(99)00439-7
Klatt, 2000, Regulation of protein function by S glutathiolation in response to oxidative and nitrosative stress, Eur. J. Biochem., 267, 4928, 10.1046/j.1432-1327.2000.01601.x
Ridnour, 2004, The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations, Biol. Chem., 385, 1, 10.1515/BC.2004.001
Siems, 1995, 4-Hydroxynonenal formation during ischemia and reperfusion of rat small-intestine, Life Sci., 57, 785, 10.1016/0024-3205(95)02006-5
Fedtke, 1990, Vinyl chloride-induced DNA adducts. 2. Formation and persistence of 7-2-oxoethylguanine and n2,3-ethenoguanine in rat-tissue DNA, Carcinogenesis, 11, 1287, 10.1093/carcin/11.8.1287
Fink, 1997, Mutagenicity in E. coli of the major DNA adduct derived from the endogenous mutagen malondialdehyde, Proc. Natl. Acad. Sci. U. S. A., 94, 8652, 10.1073/pnas.94.16.8652
Mao, 1999, DNA duplex catalyzes the chemical rearrangement of a malondialdehyde deoxyguanosine adduct, Proc. Natl. Acad. Sci. U. S. A., 96, 6615, 10.1073/pnas.96.12.6615
Marnett, 1999, Lipid peroxidation – DNA damage by malondialdehyde, Mutat. Res. Fundam. Mol. Mech. Mutagen, 424, 83, 10.1016/S0027-5107(99)00010-X
Wang, 1996, Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues, Cancer Epidemiol. Biomark. Prev., 5, 705
Stadtman, 2004, Role of oxidant species in aging, Curr. Med. Chem., 11, 1105, 10.2174/0929867043365341
Dalle, 2003, Protein carbonylation in human diseases, Trends Mol. Med., 9, 169, 10.1016/S1471-4914(03)00031-5
Dalle-Donne, 2005, Proteins as biomarkers of oxidative/nitrosative stress in diseases: the contribution of redox proteomics, Mass Spectrom. Rev., 24, 55, 10.1002/mas.20006
Chen, 2005, Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications, Biochim. Biophys. Acta, 1746, 1, 10.1016/j.bbamcr.2005.08.001
Ghezzi, 2012, Assembly factors of human mitochondrial respiratory chain complexes: physiology and pathophysiology, Adv. Exp. Med. Biol., 748, 65, 10.1007/978-1-4614-3573-0_4
Wei, 2001, Oxidative stress in human aging and mitochondrial disease-consequences of defective mitochondrial respiration and impaired antioxidant enzyme system, Chin. J. Physiol., 44, 1
Selivanov, 2011, Reactive oxygen species production by forward and reverse electron fluxes in the mitochondrial respiratory chain, PLoS Comput. Biol., 7, e1001115, 10.1371/journal.pcbi.1001115
Finkel, 2000, Oxidants, oxidative stress and the biology of ageing, Nature, 408, 239, 10.1038/35041687
Hollensworth, 2000, Glial cell type-specific responses to menadione-induced oxidative stress, Free Radical Biol. Med., 28, 1161, 10.1016/S0891-5849(00)00214-8
Van, 2006, Role of mitochondrial DNA in toxic responses to oxidative stress, DNA Repair (Amsterdam), 5, 145, 10.1016/j.dnarep.2005.03.002
Voets, 2012, Transcriptional changes in OXPHOS complex I deficiency are related to anti-oxidant pathways and could explain the disturbed calcium homeostasis, Biochim. Biophys. Acta (BBA) Mol. Basis Dis., 1822, 1161, 10.1016/j.bbadis.2011.10.009
Castro, 2012, Aging increases mitochondrial DNA damage and oxidative stress in liver of rhesus monkeys, Exp. Gerontol., 47, 29, 10.1016/j.exger.2011.10.002
Alexeyev, 2009, Is there more to aging than mitochondrial DNA and reactive oxygen species?, FEBS J., 276, 5768, 10.1111/j.1742-4658.2009.07269.x
Sas, 2007, Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders, J. Neurol. Sci., 257, 221, 10.1016/j.jns.2007.01.033
Andreazza, 2010, Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder, Arch. Gen. Psychiatry, 67, 360, 10.1001/archgenpsychiatry.2010.22
Ghezzi, 2012, Assembly factors of human mito-chondrial respiratory chain complexes: physiology and pathophysiology, Adv. Exp. Med. Biol., 748, 65, 10.1007/978-1-4614-3573-0_4
Federico, 2012, Mitochondria, oxidative stress and neurodegeneration, J. Neurol. Sci., 322, 254, 10.1016/j.jns.2012.05.030
Wang CH1, 2013, Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging, Exp. Biol. Med., 238, 450, 10.1177/1535370213493069
Guo, 2013, Oxidative stress, mitochondrial damage and neurodegenerative diseases, Neural Regen. Res., 8, 2003
Zhao, 2013, Oxidative stress and the pathogenesis of Alzheimer’s disease, Oxid. Med. Cell. Longevity, 316523, 1
Meraz-Ríos, 2014, Early onset Alzheimer’s disease and oxidative stress, Oxid. Med. Cell. Longevity, 375968, 1, 10.1155/2014/375968
Rizzuto, 1999, Mitochondria as biosensors of calcium microdomains, Cell Calcium, 26, 193, 10.1054/ceca.1999.0076
Zucker, 1999, Calcium and activity-dependent synaptic plasticity, Curr. Opin. Neurobiol., 9, 305, 10.1016/S0959-4388(99)80045-2
Rizzuto, 2005, Mitochondria as all-round players of the calcium game, J. Physiol., 29, 37
Soderling, 2000, CaM-kinases modulators of synaptic plasticity, Curr. Opin. Neurobiol., 10, 375, 10.1016/S0959-4388(00)00090-8
Sabatini, 2001, Ca(2+) signaling in dendritic spines, Curr. Opin. Neurobiol., 11, 349, 10.1016/S0959-4388(00)00218-X
Celsi, 2009, Mitochondria, calcium and cell death: a deadly triad in neurodegeneration, Biochim. Biophys. Acta, 1787, 335, 10.1016/j.bbabio.2009.02.021
Buchholz, 2007, Age-dependent changes in Ca2+ homeostasis in peripheral neurones: implications for changes in function, Aging Cell, 6, 285, 10.1111/j.1474-9726.2007.00298.x
Sochocka, 2013, Vascular oxidative stress and mitochondrial failure in the pathobiology of Alzheimer’s disease: a new approach to therapy, CNS Neurol. Disord. Drug Targets Former. Curr. Drug Targets CNS Neurol. Disord., 12, 870
Gilgun-Sherki, 2001, Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier, Neuropharmacology, 40, 959, 10.1016/S0028-3908(01)00019-3
Velayutham, 2011, Removal of H2O2 and generation of superoxide radical: role of cytochrome c and NADH, Free Radic. Biol. Med., 51, 160, 10.1016/j.freeradbiomed.2011.04.007
Uttara, 2009, Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options, Curr. Neuropharmacol., 7, 65, 10.2174/157015909787602823
Nemoto, 2000, Role for mitochondrial oxidants as regulators of cellular metabolism, Mol. Cell. Biol., 20, 7311, 10.1128/MCB.20.19.7311-7318.2000
Shohami, 1997, Oxidative stress in closed-head injury: brain antioxidant capacity as an indicator of functional outcome, J. Cereb. Blood Flow Metab., 17, 1007, 10.1097/00004647-199710000-00002
McKhann, 1984, Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease, Neurology, 34, 939, 10.1212/WNL.34.7.939
Mukaetova-Ladinska, 1993, Biochemical and anatomical redistribution of tau protein in Alzheimer’s disease, Am. J. Pathol., 143, 565
Fukuchi, 1998, Alzheimer’s disease and heparin sulfate proteoglycan, Front. Biosci., 3, 327, 10.2741/A277
Bergem, 1997, The role of heredity in late-onset Alzheimer disease and vascular dementia: a twin study, Arch. Gen. Psychiatry, 54, 264, 10.1001/archpsyc.1997.01830150090013
Gatz, 2006, Role of genes and environments for explaining Alzheimer disease, Arch. Gen. Psychiatry, 63, 168, 10.1001/archpsyc.63.2.168
Roberts, 1993, On the origin of Alzheimer’s disease: a hypothesis, NeuroReport, 4, 7, 10.1097/00001756-199301000-00001
Terry, 1991, Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment, Ann. Neurol., 30, 572, 10.1002/ana.410300410
Tomlinson, 1984
Blessed, 1968, The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects, Br. J. Psychiatry, 114, 797, 10.1192/bjp.114.512.797
Braak, 1997, Staging of Alzheimer-related cortical destruction, Int. Psychogeriatr., 9, 257, 10.1017/S1041610297004973
Andreadis, 1992, Structure and novel exons of the human τ gene, Biochemistry, 31, 10626, 10.1021/bi00158a027
Glenner, 1984, The amyloid deposits in Alzheimer’s disease: their nature and pathogenesis, Appl. Pathol., 2, 357
Selkoe, 1994, Alzheimer’s disease: a central role for amyloid, J. Neuropathol. Exp. Neurol., 53, 438, 10.1097/00005072-199409000-00003
Kang, 1987, The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor, Nature, 325, 733, 10.1038/325733a0
AS, 2002, The biological role of the Alzheimer amyloid precursor protein in epithelial cells, Histochem. Cell Biol., 117, 171, 10.1007/s00418-001-0351-5
Schubert, 1989, The regulation of amyloid β protein precursor secretion and its modulatory role in cell adhesion, Neuron, 3, 689, 10.1016/0896-6273(89)90237-7
Crowther, 1985, Image reconstruction of the Alzheimer paired helical filament, EMBO J. B, 4, 3661, 10.1002/j.1460-2075.1985.tb04132.x
PRT, 2003, Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory, Prog. Neurobiol., 70, 1, 10.1016/S0301-0082(03)00089-3
Priller, 2006, Synapse formation and function ismodulated by the amyloid precursor protein, J. Neurosci., 26, 7212, 10.1523/JNEUROSCI.1450-06.2006
Kimberly, 2003, γ-Secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and pen-2, Proc. Natl. Acad. Sci. U. S. A., 100, 6382, 10.1073/pnas.1037392100
Li, 2003, Nicastrin is required for assembly of presenilin/γ-secretase complexes to mediate notch signaling and for processing and trafficking of β-amyloid precursor protein in mammals, J. Neurosci., 23, 3272, 10.1523/JNEUROSCI.23-08-03272.2003
Li, 2000, Presenilin 1 is linked with γ-secretase activity in the detergent solubilized state, Proc. Natl. Acad. Sci. U. S. A., 97, 6138, 10.1073/pnas.110126897
Yu, 2000, Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing, Nature, 407, 48, 10.1038/35024009
Sakono, 2010, Amyloid oligomers: formation and toxicity of Aβ oligomers, FEBS J., 277, 1348, 10.1111/j.1742-4658.2010.07568.x
Kulic, 2012, Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation, Transl. Psychiatry, 2, e183, 10.1038/tp.2012.109
Benilova, 2012, The toxic Aβ oligomer and Alzheimer’s disease: an emperor in need of clothes, Nat. Neurosci., 15, 349, 10.1038/nn.3028
MAD, 1996, Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer’s disease: possible relation to oxidative stress, J. Neurol. Sci., 143, 137
Opazo, 2002, Metalloenzyme-like activity of Alzheimer’s Disease β-amyloid Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H2O2, J. Biol. Chem., 277, 40302, 10.1074/jbc.M206428200
Jiang, 2009, Ternary complexes of iron, amyloid-β, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer’s disease, Biochemistry, 48, 7939, 10.1021/bi900907a
Cuajungco, 2000, Evidence that the β-amyloid plaques of Alzheimer’s disease represent the redox-silencing and entombment of Aβ by zinc, J. Biol. Chem., 275, 19439, 10.1074/jbc.C000165200
Feeney, 2008, Vulnerability of glial cells to hydrogen peroxide in cultured hippocampal slices, Brain Res., 1198, 1, 10.1016/j.brainres.2007.12.049
Giasson, 2000, A new link between pesticides and Parkinson’s disease, Nat. Neurosci., 3, 1227, 10.1038/81737
Lindqvist, 2012, Non-motor symptoms in patients with Parkinson’s disease – correlations with inflammatory cytokines in serum, PLoS One, 7, e47387, 10.1371/journal.pone.0047387
Schapira, 2011, Etiology and pathogenesis of Parkinson’s disease, Mov. Disord., 26, 1049, 10.1002/mds.23732
Slivka, 1985, Hydroxyl radical attack on dopamine, J. Biol. Chem., 260, 15466, 10.1016/S0021-9258(17)36277-4
Fornstedt, 1990, In vivo autoxidation of dopamine in guinea pig striatum increases with age, J. Neurochem., 55, 655, 10.1111/j.1471-4159.1990.tb04183.x
Fasano, 2006, Modifications of the iron–neuromelanin system in Parkinson’s disease, J. Neurochem., 96, 909, 10.1111/j.1471-4159.2005.03638.x
Sulzer, 2000, Intraneuronal dopamine–quinone synthesis: a review, Neurotox. Res., 1, 181, 10.1007/BF03033289
Mann, 1984, Postmortem monoamine oxidase enzyme kinetics in the frontal cortex of suicide victims and controls, Acta Psychiatry Scand., 69, 135, 10.1111/j.1600-0447.1984.tb02477.x
Jossan, 1991, Quantitative localization of human brain monoamine oxidase B by large section autoradiography using L-[3H]deprenyl, Brain Res., 547, 69, 10.1016/0006-8993(91)90575-G
Strolin, 1989, Monoamine oxidase, brain ageing and degenerative diseases, Biochem. Pharmacol., 38, 555, 10.1016/0006-2952(89)90198-6
Morgan, 1987, Dopamine and serotonin systems in human and rodent brain: effects of age and neurodegenerative disease, J. Am. Geriatr. Soc., 35, 334, 10.1111/j.1532-5415.1987.tb04641.x
Kish, 1992, Aging produces a specific pattern of striatal dopamine loss: Implications for the etiology of idiopathic Parkinson’s disease, J. Neurochem., 58, 642, 10.1111/j.1471-4159.1992.tb09766.x
Thannickal, 2008, Hypocretin (orexin) and melanin concentrating hormone loss and the symptoms of Parkinson’s disease, Brain, 131, e87, 10.1093/brain/awm221
Bosco, 2006, Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization, Nat. Chem. Biol., 2, 249, 10.1038/nchembio782
Nakabeppu, 2007, Oxidative damage in nucleic acids and Parkinson’s disease, J. Neurosci. Res., 85, 919, 10.1002/jnr.21191
Zeevalk, 2008, Glutathione and Parkinson’s disease: is this the elephant in the room?, Biomed. Pharmacother., 62, 236, 10.1016/j.biopha.2008.01.017
Halliwell, 1992, Reactive oxygen species and the central nervous system, J. Neurochem., 59, 1609, 10.1111/j.1471-4159.1992.tb10990.x
Parker, 1989, Abnormalities of the electron transport chain in idiopathic Parkinson’s disease, Ann. Neurol., 26, 719, 10.1002/ana.410260606
Bender, 2006, High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease, Nat. Genet., 38, 515, 10.1038/ng1769
Müftüoglu, 2004, Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations, Mov. Disord., 19, 544, 10.1002/mds.10695
Palacino, 2004, Mitochondrial dysfunction and oxidative damage in Parkin-deficient mice, J. Biol. Chem., 279, 18614, 10.1074/jbc.M401135200
Gandhi, 2009, PINK1-associated Parkinson’s disease is caused by neuronal vulnerability to calcium-induced cell death, Mol. Cell, 33, 627, 10.1016/j.molcel.2009.02.013
Irrcher, 2010, Loss of the Parkinson’s disease-linked gene DJ-1 perturbs mitochondrial dynamics, Hum. Mol. Genet., 19, 3734, 10.1093/hmg/ddq288
Devi, 2008, Mitochondrial import and accumulation of α-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain, J. Biol. Chem., 283, 9089, 10.1074/jbc.M710012200
Martin, 2006, Parkinson’s disease α-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death, J. Neurosci., 26, 41, 10.1523/JNEUROSCI.4308-05.2006
McGeer, 1988, Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains, Neurology, 38, 1285, 10.1212/WNL.38.8.1285
Yamada, 1993, Histological and biochemical pathology in a family with autosomal dominant Parkinsonism and dementia, Neurol. Psychiatry Brain Res., 2, 26
O’Callaghan, 1990, Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine, Brain Res., 521, 73, 10.1016/0006-8993(90)91526-M
Qian, 2010, Neuroinflammation is a key player in Parkinson’s disease and a prime target for therapy, J. Neural Transm., 117, 971, 10.1007/s00702-010-0428-1
Ishikawa, 1998, Clinical and neuropathological aspects of autosomal recessive juvenile parkinsonism, J. Neurol., 245, 4, 10.1007/PL00007745
Langston, 1999, Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine exposure, Ann. Neurol., 46, 598, 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F
Wilms, 2003, Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson’s disease, FASEB J., 17, 500, 10.1096/fj.02-0314fje
Zecca, 2008, Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson’s disease, Acta Neuropathol., 116, 47, 10.1007/s00401-008-0361-7
Lee, 2005, Intravesicular localization and exocytosis of alpha-synuclein and its aggregates, J. Neurosci., 25, 6016, 10.1523/JNEUROSCI.0692-05.2005
Borghi, 2000, Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson’s disease and normal subjects, Neurosci. Lett., 287, 65, 10.1016/S0304-3940(00)01153-8
El-Agnaf, 2003, Alpha-synuclein implicated in Parkinson’s disease is present in extracellular biological fluids, including human plasma, FASEB J., 17, 1945, 10.1096/fj.03-0098fje
Zhang, 2005, Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson’s disease, FASEB J., 19, 533, 10.1096/fj.04-2751com
Farina, 2007, Astrocytes are active players in cerebral innate immunity, Trends Immunol., 28, 138, 10.1016/j.it.2007.01.005
Gao, 2008, Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration, J. Neurosci., 28, 7687, 10.1523/JNEUROSCI.0143-07.2008
Gao, 2011, Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson’s disease, Environ. Health Perspect., 119, 807, 10.1289/ehp.1003013
Kim, 2005, Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia, J. Neurosci., 25, 3701, 10.1523/JNEUROSCI.4346-04.2005
Choi, 2008, A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells, J. Neurochem., 106, 405, 10.1111/j.1471-4159.2008.05399.x
Kim, 2010, Matrix metalloproteinase-3 is increased and participates in neuronal apoptotic signaling downstream of caspase-12 during endoplasmic reticulum stress, J. Biol. Chem., 285, 16444, 10.1074/jbc.M109.093799
Kim, 2011, Role of matrix metalloproteinase-3 in neurodegeneration, J. Neurochem., 116, 22, 10.1111/j.1471-4159.2010.07082.x
Kim, 2007, A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation, FASEB J., 21, 179, 10.1096/fj.06-5865com
Lee, 2010, Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1, J. Immunol., 185, 615, 10.4049/jimmunol.0903480
Vu, 1991, Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation, Cell, 64, 1057, 10.1016/0092-8674(91)90261-V
Suo, 2002, Participation of protease-activated receptor-1 in thrombin-induced microglial activation, J. Neurochem., 80, 655, 10.1046/j.0022-3042.2001.00745.x
Schönbeck, 1998, Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing, J. Immunol., 161, 3340, 10.4049/jimmunol.161.7.3340
Woo, 2008, Inhibition of MMP-3 or -9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia, J. Neurochem., 106, 770, 10.1111/j.1471-4159.2008.05430.x
Jian, 2005, Matrix metalloproteinases and free radicals in cerebral ischemia, Free Radic. Biol. Med., 39, 71, 10.1016/j.freeradbiomed.2005.03.033